0001225208-24-002096.txt : 20240214 0001225208-24-002096.hdr.sgml : 20240214 20240214183613 ACCESSION NUMBER: 0001225208-24-002096 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240212 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Decker Robert J CENTRAL INDEX KEY: 0001798703 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 24641265 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 doc4.xml X0508 4 2024-02-12 0000200406 JOHNSON & JOHNSON JNJ 0001798703 Decker Robert J ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 VP Corporate Controller 0 Common Stock 2024-02-12 4 M 0 1637.0000 0.0000 A 18994.0000 D Common Stock 2024-02-12 4 M 0 275.0000 0.0000 A 19269.0000 D Common Stock 2024-02-12 4 F 0 523.0000 157.4000 D 18746.0000 D Common Stock 597.0000 I By 401k Common Stock 134.0000 I By ESOP Performance Share Units 2024-02-12 4 M 0 1637.0000 0.0000 D 2024-02-08 Common Stock 1637.0000 0.0000 D Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Shares earned due to performance factor of 116.8% upon certification of performance results by the Board. Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024). Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024). /s/ Raavi K. Deol, as attorney-in-fact for Robert J. Decker 2024-02-14